Sage Therapeutics Inc (DELISTED) (SAGE:DL)
8.68
0.00 (0.00%)
USD |
NASDAQ |
Aug 04, 16:00
Sage Therapeutics Shareholders Equity (Quarterly): 368.74M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.050B |
| Biogen, Inc. | 18.21B |
| Eli Lilly & Co. | 23.79B |
| Sarepta Therapeutics, Inc. | 1.320B |
| IGM Biosciences, Inc. (DELISTED) | 100.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 422.92M |
| Total Liabilities (Quarterly) | 54.18M |
| Current Ratio | 9.164 |